Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | SLDBSolid Biosciences Inc.FY2022 · Dec |
|---|---|
| Revenue | $8.09M |
| Revenue, yoy | −40.6% |
| Net income | $174.33M |
| Net income, yoy | −39.8% |
| Net margin | — |
| Free cash flow | $157.44M |
| FCF margin | — |
| EPS, diluted | $1.99 |
Add another company.